SCHEMBL13637136

SCHEMBL13637136

CN1CCC(=O)N(CC2COC(C)(C)O2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GAA P10253 1/20 0.40
TMEM97 Q5BJF2 2/20 0.40
SIGMAR1 Q99720 2/20 0.40
MAPK14 Q16539 4/20 0.39
CA2 P00918 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
NAMPT P43490 3/20 0.34
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13315032 0.83 ALDH1A1 (0.41) ALDH1A1NPSR1TMEM97SIGMAR1MAPK14
SCHEMBL10447231 0.81 CA2 (0.41) ALDH1A1NPSR1GAATMEM97SIGMAR1
SCHEMBL3543202 0.80 ALDH1A1 (0.45) ALDH1A1NPSR1TMEM97SIGMAR1MAPK14
SCHEMBL18498742 0.75 ALDH1A1 (0.46) ALDH1A1NPSR1TMEM97SIGMAR1MAPK14
SCHEMBL18498745 0.75 ALDH1A1 (0.46) ALDH1A1NPSR1TMEM97SIGMAR1MAPK14
SCHEMBL18498798 0.75 TMEM97 (0.46) ALDH1A1NPSR1TMEM97SIGMAR1MAPK14
SCHEMBL3551604 0.70 ALDH1A1 (0.47) ALDH1A1NPSR1TMEM97SIGMAR1CA2
SCHEMBL30503761 0.69 ALDH1A1 (0.48) ALDH1A1NPSR1TMEM97SIGMAR1CA2
SCHEMBL13232574 0.69 ALDH1A1 (0.47) ALDH1A1NPSR1TMEM97SIGMAR1KDM4E
SCHEMBL15735798 0.68 ALDH1A1 (0.39) ALDH1A1NPSR1TMEM97SIGMAR1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612200-B2 Inhibitors of protein kinases LOCUS PHARMACEUTICALS, INC. (US) 2009-11-03 US disclosed
US-20070185098-A1 Inhibitors of protein kinases LOCUS PHARMACEUTICALS, INC. (US) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185098-A1 Inhibitors of protein kinases MAP3K20, MAP3K1, MAP3K19 ALDH1A1 4567/4885NPSR1 2761/4885GAA 2137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.